Cargando…

What causes exertional dyspnoea in patients with atrial fibrillation? Implications for catheter ablation in patients with heart failure

Detalles Bibliográficos
Autor principal:	Packer, Milton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd. 2021
Materias:	HFpEF
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360079/ https://www.ncbi.nlm.nih.gov/pubmed/33768688 http://dx.doi.org/10.1002/ejhf.2164

Ejemplares similares

Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction
por: Chandramouli, Chanchal, et al.
Publicado: (2022)

Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM‐HFpEF)
por: Linde, Cecilia, et al.
Publicado: (2022)

Effects of Exercise Training on Cardiac Function in Heart Failure with Preserved Ejection Fraction
por: Fukuta, Hidekatsu
Publicado: (2020)

Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives
por: van Woerden, Gijs, et al.
Publicado: (2022)

Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS‐HFpEF study
por: Venkateshvaran, Ashwin, et al.
Publicado: (2022)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction
por: Teramoto, Kanako, et al.
Publicado: (2022)

Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis
por: Bilak, Joanna M, et al.
Publicado: (2022)

Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy – A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology
por: Guazzi, Marco, et al.
Publicado: (2022)

Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: Rationale for and Practical Use of a Successful Therapy
por: Gori, Mauro, et al.
Publicado: (2022)

Clinical Evidence and Proposed Mechanisms of Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Class Effect?
por: Deschaine, Brent, et al.
Publicado: (2022)

Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction
por: Uijl, Alicia, et al.
Publicado: (2021)

Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction
por: Woolley, Rebecca J., et al.
Publicado: (2021)

Epicardial Fat in Heart Failure with Preserved Ejection Fraction: Bad Actor or Just Lying Around?
por: Oduah, Mary-Tiffany, et al.
Publicado: (2023)

Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillation
por: Packer, Milton
Publicado: (2019)

Methodological and Clinical Heterogeneity and Extraction Errors in Meta‐Analyses of Catheter Ablation for Atrial Fibrillation in Heart Failure
por: Packer, Milton
Publicado: (2019)

Stridor and dyspnoea after ablation for atrial fibrillation
por: Waleed, Khalid Bin, et al.
Publicado: (2023)

Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure
por: Scanavacca, Mauricio, et al.
Publicado: (2018)

Atrial Fibrillation Mechanisms and Implications for Catheter Ablation
por: Cheniti, Ghassen, et al.
Publicado: (2018)

Catheter ablation of atrial fibrillation: recent advances and future challenges
por: Hindricks, Gerhard, et al.
Publicado: (2022)

Evaluation of high‐sensitivity C‐reactive protein and uric acid in vericiguat‐treated patients with heart failure with reduced ejection fraction
por: Kramer, Frank, et al.
Publicado: (2020)

The impact of catheter ablation for atrial fibrillation in heart failure
por: Moschonas, Konstantinos, et al.
Publicado: (2018)

Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
por: Al-Jazairi, M. I. H., et al.
Publicado: (2019)

Catheter ablation in patients with persistent atrial fibrillation
por: Kirchhof, Paulus, et al.
Publicado: (2017)

Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata
por: Stolfo, Davide, et al.
Publicado: (2022)

Catheter Ablation for Atrial Fibrillation
por: Gauri, Andre J, et al.
Publicado: (2003)

Sex-Related Differences in Catheter Ablation for Patients With Atrial Fibrillation and Heart Failure
por: Chibber, Tamanna, et al.
Publicado: (2020)

Benefit of Catheter Ablation for Atrial Fibrillation in Heart Failure Patients with Different Etiologies
por: Long, Songbing, et al.
Publicado: (2023)

Exertional dyspnoea in obesity
por: Bernhardt, Vipa, et al.
Publicado: (2016)

Prognostic Implications and Efficacy of Catheter Ablation by Atrial Fibrillation Type
por: Miyama, Hiroshi, et al.
Publicado: (2023)

Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial
por: Voors, Adriaan A., et al.
Publicado: (2020)

Catheter ablation of atrial fibrillation in patients with diabetes mellitus
por: Wang, Allen, et al.
Publicado: (2020)

Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
por: Nasso, Giuseppe, et al.
Publicado: (2021)

Cryoballoon Catheter Ablation in Atrial Fibrillation
por: Ozcan, Cevher, et al.
Publicado: (2011)

Catheter ablation of atrial fibrillation in the elderly
por: Lioni, Louiza, et al.
Publicado: (2014)

Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure
por: Yang, Pil-Sung, et al.
Publicado: (2021)

Healthcare utilization and cost in patients with atrial fibrillation and heart failure undergoing catheter ablation
por: Field, Michael E., et al.
Publicado: (2020)

Cost‐Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation
por: Lau, Darren, et al.
Publicado: (2021)

Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure
por: Kawaji, Tetsuma, et al.
Publicado: (2020)

Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: Current Evidence and Future Opportunities
por: Suzuki, Sho, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5gipnejd03r1ucvipv66khu4vj